Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 18, 1988 - Issue 5
56
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Disposition of (—)-fenfluramine and its active metabolite, (—)-norfenfluramine in rat: A single dose-proportionality study

, , , &
Pages 573-584 | Received 17 Jul 1987, Accepted 01 Jan 1988, Published online: 30 Sep 2009
 

Abstract

1. The disposition of (—)-fenfluramine, (—)-F, was studied in rats after i.v. and oral administration (1˙25 to 12˙5 mg/kg). Whole blood-to-plasma ratio and the protein binding (determined by equilibrium dialysis) of the compound and its main active metabolite, (—)-norfenfluramine (—)-NF, were investigated.

2. The bound fraction of both compounds (about 40%) was constant in the concentration range of 1-10 nmol/ml. The whole blood to plasma concentration ratios of (—)-F and (—)-NF were larger than unity and were constant over this dose range.

3. The drug followed apparent first-order kinetics, at doses up to 6˙25 mg/kg. The mean half-lives of the parent drug and its metabolite were about 1 and 12 h respectively. The volume of distribution of (—)-F was large and total body clearance approached liver blood flow.

4. Oral doses were rapidly absorbed from the rat gastrointestinal tract. Bioavailability of the drug was about 20%. Urinary excretion of unchanged drug (3-4% of dose) and its metabolite (about 20%) were similar after i.v. and oral administration.

5. After larger doses (12˙5 mg/kg) the kinetics of (—)-F were nonlinear. The AUC increased, but not in proportion to the dose, and kinetic parameters were modified.

6. Brain concentrations reflected the dose-related changes observed in (—)-F and (—)-NF blood concentrations, and patterns of brain distribution and subcellular localization of the drug and its metabolite were modified at the highest dose tested.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.